OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q2 2019 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc (OPNT)
Q2 2019 Earnings Conference Call
August 8, 2019 4:30 PM ET
Company Participants
Lisa Sher – Senior Director of Investor Relations and Communications
Roger Crystal – Chief Executive Officer
David O'Toole – Chief Financial Officer
Conference Call Participants
Brandon Folkes – Cantor Fitzgerald
Carl Byrnes – Northland Capital Market
Presentation
Operator
Greetings, and welcome to the Opiant Pharmaceuticals Second Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Lisa Sher, Senior Director of Investor Relations and